TB Host Directed Therapy
NCT02968927
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Tuberculosis
Interventions
DRUG:
Everolimus 0.5 MG
DRUG:
Auranofin 6 MG
DRUG:
Vitamin D3
DRUG:
CC-11050
DRUG:
2HRbZE/4HRb
Sponsor
The Aurum Institute NPC